CODX vs MCO · rev $3.9M vs P/E 33, rev $7.72B
Co-Diagnostics, Inc. Common Stock (CODX) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MCO revenue for 2025-12-31 was $7.72B. Net income was $2.46B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
CODX currently screens at market cap $31.4M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the CODX and MCO stock pages for the full models.
Not investment advice.